Co-occurrence of KRAS G12D and Mutant TP53 Predicts Improved Outcome in Surgically Resected Pancreatic Ductal Adenocarcinoma
Year: 2022
Type: article
Study design: Observational Study
Source: HPB
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4313032036
